Granulomatous infections due to tumor necrosis factor blockade: Correction [4]

Clinical Infectious Diseases

Volumn 39, Issue 8, 2004, Pages 1254-1255

  Wallis, Robert S ^a,d,f   Broder, Michael ^b,e   Wong, John ^b,e   Beenhouwer, David ^c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b Zynx Health   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Pharmaceutical Product Development   (United States)

^e PARTNERSHIP FOR HEALTH ANALYTIC RESEARCH   (United States)

^f RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR;

COCCIDIOIDOMYCOSIS; GRANULOMATOSIS; HISTOPLASMOSIS; HUMAN; IMMUNITY; LETTER; LISTERIOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; TUBERCULOSIS; TUMOR NECROSIS;

ANTIBODIES, MONOCLONAL; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12844254964     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/424455     Document Type: Letter

References (3)

1. Wallis RS, Broder MS, Wong JY, Hanson JY, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38:1261-5.
2. Ott L. An introduction to statistical methods and data analysis. 3rd ed. Boston: PSW-Kent, 1988:217-86.
3. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2000. Atlanta GA: United States Department of Health and Human Services, 2001. Available at: http://www.cdc.gov/nchstp/tb/surv/surv2000/ default.htm. Accessed 31 August 2004.